ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PHC Plant Health Care Plc

8.825
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 8.825 8.80 8.85 - 345,845 16:29:55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pesticides, Agric Chems, Nec 11.21M -4M -0.0117 -7.54 30.14M
Plant Health Care Plc is listed in the Pesticides, Agric Chems sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 8.83p. Over the last year, Plant Health Care shares have traded in a share price range of 3.20p to 10.00p.

Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £30.14 million. Plant Health Care has a price to earnings ratio (PE ratio) of -7.54.

Plant Health Care Share Discussion Threads

Showing 526 to 548 of 1425 messages
Chat Pages: Latest  33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
18/4/2018
08:25
Thanks for the link paulfred1.He does sound upbeat but again seems to kick the can down the road regarding the first license,now saying by the end of 2018 .Also if he is saying that breakeven is possible for 2019 but only if further licenses are auctioned then that doesn't indicate to me the value for each of them will be that high taking in to consideration that 2019 should also have royalty payments for the first license plus 20% increase in revenue on their commercial products.Any further delays and its going to be more cash burn i feel in 2019 as well
riddlerone
17/4/2018
09:55
Thank you wan - very helpful!
coincall
17/4/2018
09:26
It is worth anyone new to PHC also listening to the recent interview, a link for which is in the header.
wan
17/4/2018
09:24
I have created a new PHC thread -
wan
17/4/2018
09:21
Plant Health Care; Using novel biological products to address global agricultural markets

Plant Health Care is one of the leading providers of natural, plant yield enhancing products to the agricultural industry.

The Company has focused on selling or licensing its technologies in global agricultural markets in order to achieve the greatest return for its shareholders.

One of the rapidly growing trends in agriculture is biologicals. Vast sums are being made available for research and product development, and also via strategic partnerships and M&A in order to bring effective biological products to market.

To exemplify the interest, importance and potential size of this emerging market, one only has to look at Bayer's efforts and deal making regarding Biologics. In one example Bayer have partnered with Ginkgo Bioworks in a $100m funded venture. Another ag giant, Monsanto, has also been ramping up its biologicals portfolio, and not to mention the fact that Bayer is in the final stages of acquiring Monsanto!

Plant Health Care has already entered this market, with sales of their Harpin range of products recording impressive growth, importantly their Harpin Alpha Beta product appears to offer further growth potential going forwards, via additional crop targets and new distribution agreements.

Whilst the benefits of certain biolgicals to agriculture is widely recognised, bringing such products to market is not straight forward. Putting regulatory issues to one side (which in any regard should be more straight forward and quicker than bringing synthetic chemistry through the regulatory process). The very nature of biologics e.g. living organisms and bioactive compounds, means they are not as hardy and shelf stable as their synthetic alternatives, as they tend to degrade rapidly in heat and sunlight and have limited storage lives.

PHC's new technology offering, PREtec overcomes the instability associated with most biologics and are applicable to a wide range of crops. The first target market for PREtec is in soybeans to protect against soybean rust resistance and increase yields.

Soybeans represent a very large global market, and Asian Soybean Rust (ASR) is a major issue, particularly in Brazil where ASR is developing resistance even to the most advanced chemical fungicides in the market. PHC and their evaluation partners are trialing Pretec in Brazil soybeans and data from these ASR trials are due in Q2 2018.

Four global agricultural/seed majors are running field trials in Brazil of Innatus 3G added to chemical sprays for the control of Asian Soybean Rust (ASR), a devastating fungal disease of soybeans. Farmers spent US$1.7 billion on soybean fungicides in 2016 in Brazil; there are increasing concerns about disease resistance and the resulting impact on yield.

In the Company's trials, their lead peptides have shown promise for the control of ASR, especially for the control of resistant disease when used in mixture with conventional agrochemicals.

Exclusive rights to Innatus 3G for use in South American soybeans are expected to be licenced through a competitive licencing process in the second half of 2018.

Soybean rust resistance has evolved faster than the chemical companies have been able to adjust, to the extent that their chemicals have become less effective. If Plant Health Care's PREtec offering is proven to control of Asian Soybean Rust, then on its on its own this could be a company transforming product!

The use of PREtec in other markets and crops is also being evaluated;
PHC expanded its programme of trials in other crops. Results continued to show good performance for Innatus 3G under disease and drought stress, and for T-Rex 3G against nematodes. Y-Max 3G peptides increased yields even under optimal growing conditions.

Discussions continue with partners about future licencing of Innatus 3G in other crops and regions and of both T-Rex 3G and Y-Max 3G.

All five of the top global agricultural/seed companies and a number of other companies are testing lead peptides from PHC's PREtec platforms Innatus(TM) 3G, T-Rex 3G and Y-Max 3G.

2018 could well prove to be a decisive period for PHC, with 2019 providing further potential for material value and growth events to be realised.

The following interview on April 16th 2018 is worth listening to -

Plant Health Care website -

Please conduct your own research when making investment decisions, as the originator, or the threads contributors, could be either wrong or inaccurate.

wan
16/4/2018
08:13
Very good interview on Directors Talk - v upbeat!
paulfred1
13/4/2018
07:45
It does appear that this year could be a decisive year for PHC.

I am particularly attracted here by Plant Health Care's new technology offerings.

Soybean rust resistance has evolved faster than the chemical companies have been able to adjust, to the extent that their chemicals have become less effective.
If Plant Health Care's PHC279 is proven to control of Asian Soybean Rust, then on its on its own this could be a company transforming product!

Trial results for PHC279 are due in the second half of 2018, and I note that the soybean harvest is well advanced and complete is some areas of Brazil, with soybean rust presenting and causing yield loss in some areas -

April 11, 2018
2017/18 Brazilian Soybean Crop over Three Quarters Harvested
Author: Michael Cordonnier/Soybean & Corn Advisor, Inc.

The Brazilian soybean crop is 77% harvested compared to 82% last year and 77% for the 5-year average according to AgRural. The harvest is complete in central Brazil. In southern Brazil the soybeans are 84% harvested in Parana, 40% in Santa Catarina, and 35% in Rio Grande do Sul. The early yields in Rio Grande do Sul were better than expected, but the yields of the later maturing soybeans are less than expected. They blame the disappointing yields on soybean rust. Rio Grande do Sul ended up with the most cases of soybean rust in Brazil.

Full story -

wan
10/4/2018
10:29
It doesnt look like that to me as new business from sugar cane should improve revenue,more delays in the much touted auctions is the annoying thing.They desperately need one of these to happen to prove the value and hence the market cap.
riddlerone
10/4/2018
10:29
Why would they want to say anything about Q1, other than as they have which is to confirm Brazil sugar cane?
trcml
10/4/2018
10:17
Wonder if the outlook is a veiled half one warning. Didn't say much about Q1
zipstuck
11/3/2018
15:00
Plant Health Care Announces H2Copla Launch in partnership with Coplacana in Brazil

hxxp://www.planthealthcare.com/plant-health-care-announces-h2copla-launch-partnership-coplacana-brazil/

riddlerone
06/3/2018
07:11
Dubai123,thanks I didn't know the disclosure rules had been changed.
riddlerone
05/3/2018
22:19
Hey just posted something that might be of interest to you
dubai123
05/3/2018
22:18
Two things1. Under new rules post MiFID II institutions only need to disclose through 5% as opposed to 3%. Retail guys same old rules2. See this Bloomberg article of Asian soya bean. The opportunity here is massive for plant healthcarehttps://www.google.co.uk/amp/s/www.bloomberg.com/amp/news/articles/2017-12-21/killer-fungus-threatens-brazilian-farms-as-pesticides-lose-power
dubai123
04/3/2018
10:04
From last weeks placing we know
Directors 700k
RG 7m
Polar Capital 2m

From a 25m placing we still have approx 15m unaccounted for so far.
You have to hope that the market makers will have taken a fair share of that
and i cant see that they were running a short book so it certainly points to a rise in the coming weeks.
Anyone interested keep your eye on this site as they are a key tie up with PHC
hxxps://www.embrapa.br/en/noticias

riddlerone
27/2/2018
21:35
Very exiting times ahead. Clearly a well support raise
dubai123
27/2/2018
17:53
So fully subscribed,cant wait to see the holdings declared after these list on Thursday.
riddlerone
27/2/2018
16:20
Good old Richard, puts his money where his mouth is.
chadders
27/2/2018
14:12
A smart move in my view. Strengthen the balance sheet in advance of what may be a keenly contested auction.
chadders
27/2/2018
07:19
Placing price higher than expected - Not significant dilution (imo)
pugugly
27/2/2018
07:16
Well that was always on the cards,good to see at a decent price.Well supported by the directors and hopefully will be fully subscribed by lunchtime today.
riddlerone
20/2/2018
18:31
T20's closing/Rolling over from the news and rise on 24th.We are probably still another month away from news on the end of the trials will probably pull back again till then
riddlerone
Chat Pages: Latest  33  32  31  30  29  28  27  26  25  24  23  22  Older

Your Recent History

Delayed Upgrade Clock